Synthetic peptides bind to high-affinity thrombin receptors and modulate thrombin mitogenesis.

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Signaling

Background:

• Thrombin initiates cell proliferation through receptor binding and enzymatic activity.
• Understanding thrombin's role in cell signaling is crucial for deciphering mitogenic pathways.

Purpose of the Study:

• To identify specific regions of thrombin responsible for high-affinity receptor binding and mitogenic signal generation.
• To characterize the function of synthetic peptides representing thrombin domains in cell proliferation.

Main Methods:

• Utilized synthetic peptides derived from human prothrombin (p508-530) and RGDA (p517-520).
• Assessed 125I-alpha-thrombin binding inhibition and mitogenic effects in cell cultures.
• Investigated effects on DNA synthesis in the presence and absence of phorbol myristate acetate (PMA).

Main Results:

• Peptide p508-530 significantly inhibited thrombin binding and enhanced/stimulated DNA synthesis, indicating a high-affinity binding domain.
• Peptide RGDA competed for binding but inhibited mitogenesis, acting as an antagonist.
• Non-homologous peptides showed no effect on thrombin binding or mitogenesis.

Conclusions:

• A specific region (p508-530) of thrombin contains a high-affinity receptor binding domain crucial for mitogenic signaling.
• Synthetic peptides can act as either agonists or antagonists of thrombin-induced cell proliferation, depending on their structure and signaling capacity.
• These findings elucidate the molecular mechanisms underlying thrombin's role in cell proliferation and receptor interaction.